BioSpace News Archive

“The Fight Is In Us” Campaign Seeks to Mobilize COVID-19 Survivors to Accelerate the Development of Potentially Lifesaving Therapies [26-May-2020] REDMOND, Wash. and NEW YORK , May 26, 2020 /PRNewswire/ -- A coalition of world-leading medical and research institutions, blood centers, life science companies, technology companies, philanthropic organizations

Freenome , a privately held biotechnology company that has pioneered a comprehensive multiomics platform for early cancer detection with a routine blood draw, announced several new developments: initiating its PREEMPT CRC clinical trial; adding Gary Reedy, CEO of the American

Tetra Therapeutics today announced that it has entered into a definitive merger agreement for Shionogi & Co., Ltd. to acquire Tetra. With this acquisition, Shionogi will obtain global rights to Tetra’s entire portfolio of compounds for

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Jefferies 2020 Virtual Healthcare Conference on June 2 . Joe Fitzgerald , executive vice president and president, Rhyth

CB6 demonstrated prophylactic and treatment effects in rhesus monkeys Clinical testing expected to begin in second quarter in collaboration with Eli Lilly and Company SHANGHAI, China, May 26, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877) a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announced the publication of research results from the Company’s efforts to generate therapeutic

Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced it will report its first quarter 2020 financial results after market close on Thursday, May 28, 2020.

Delta Care Rx called for an end to pharmacy pricing games and gimmicks by PBMs during the COVID-19 crisis by launching a Do-It-Yourself, no-contract/no-commitment Rx purchasing option for any hospice provider looking for more competitive pricing on the prescription medications it provides to patients.

Pendulum Therapeutics, an evidence-based microbiome company, is proud to announce that CEO and Co-Founder Colleen Cutcliffe, Ph.D., has accepted an invitation to join the Leadership Board of the American Diabetes Association, Northern California chapter.

New England Biolabs (NEB®) has announced its pledge of $100,000 to the Vaccine and Immunotherapy Center (VIC) at Mass General Hospital (MGH).

Progenity, a biotechnology company with an established track record of success in developing and commercializing molecular testing products, announced the appointment of Damon Silvestry as Chief Operating Officer.